AxoGen, Inc. | Business Contracts

Eighth Amendment to License and Services Agreement, dated as of August 22, 2022, by and between Axogen Corporation and Community Blood Center (d/b/a Community Tissue Services) (Filed With SEC on August 25, 2022)

First Amendment to Lease Agreement, dated as of August 22, 2022, by and between Axogen Corporation and Ja-Cole, L.P (Filed With SEC on August 25, 2022)

Form of Premium Incentive Stock Option Notice and Premium Incentive Stock Option Notice Agreement under the Axogen, Inc. Amended and Restated 2019 Long-Term Incentive Plan (Filed With SEC on April 1, 2022)

Option Agreement, dated June 30, 2020, between Axogen, Inc. and TPC Investments II LP (Filed With SEC on July 1, 2020)

Nerve End Cap Supply Agreement, dated June 27, 2017, by and between Cook Biotech Incorporated and Axogen Corporation (Filed With SEC on February 24, 2020)

Description of Securities of Axogen, Inc (Filed With SEC on February 24, 2020)

Form of Incentive Stock Option Notice and Incentive Stock Option Agreement under the Axogen, Inc. Amended and Restated 2019 Long-Term Incentive Plan (Filed With SEC on April 1, 2022)

Form of Restricted Stock Units Notice and Restricted Stock Units Agreement under the Axogen, Inc. Amended and Restated 2019 Long-Term Incentive Plan (Filed With SEC on April 1, 2022)

Form of Performance-Based Restricted Stock Units Notice and Performance-Based Restricted Stock Units Agreement under the Axogen, Inc. Amended and Restated 2019 Long-Term Incentive... (Filed With SEC on April 1, 2022)

Commercial Lease Amendment, dated as of January 27, 2022, by and between Axogen Corporation and Ja-Cole, L.P (Filed With SEC on January 31, 2022)

First Amendment to Office Lease, dated as of July (Filed With SEC on July 16, 2021)

Sixth Amendment to Lease, dated as of July 1 (Filed With SEC on July 16, 2021)

Seventh Amendment to License and Services Agreement, dated as of February 22, 2021, by and between Axogen Corporation and Community Blood Center (d/b/a Community Tissues Services) (Filed With SEC on February 26, 2021)

Second Amended and Restated Employment Agreement, effective January 4, 2021, between Axogen Corporation and Angelo Scopelianos (Filed With SEC on January 6, 2021)

Fifth Amendment to Lease, dated as of November 30, 2020, by and between AxoGen Corporation and SNH Medical Office Properties Trust (Filed With SEC on December 4, 2020)

Commercial Lease, dated October 1, 2020, by and between Axogen Corporation and Ja-Cole, L.P (Filed With SEC on October 30, 2020)

Amended and Restated Employment Agreement, dated November 1, 2020, by and between Axogen Corporation and Maria Martinez (Filed With SEC on October 29, 2020)

Amended and Restated Employment Agreement, dated November 1, 2020, by and between Axogen Corporation and Angelo Scopelianos (Filed With SEC on October 29, 2020)

Amended and Restated Employment Agreement, dated November 1, 2020, by and between Axogen Corporation and Bradley Ottinger (Filed With SEC on October 29, 2020)

Amended and Restated Employment Agreement, dated November 1, 2020, by and between Axogen Corporation and Isabelle Billet (Filed With SEC on October 29, 2020)

Amended and Restated Employment Agreement, dated November 1, 2020, by and between Axogen Corporation and Eric Sandberg (Filed With SEC on October 29, 2020)

Amended and Restated Employment Agreement, dated November 1, 2020, by and between Axogen Corporation and Karen Zaderej (Filed With SEC on October 29, 2020)

Amended and Restated Employment Agreement, dated November 1, 2020, by and between Axogen Corporation and Peter Mariani (Filed With SEC on October 29, 2020)

Revenue Participation Agreement, dated June 30, 2020, between Axogen, Inc. and Argo SA LLC (Filed With SEC on July 1, 2020)

Security Agreement, dated June 30, 2020, among Axogen, Inc., Axogen Corporation, AxoGen Processing Corporation, and Argo SA LLC (Filed With SEC on July 1, 2020)

Term Loan Agreement, dated June 30, 2020, among Axogen, Inc., Axogen Corporation, AxoGen Processing Corporation, TPC Investments II LP and Argo SA LLC (Filed With SEC on July 1, 2020)

Amendment No. 5 to Employment Agreement, dated as of June 1, 2020, by and between Greg Freitag and Axogen, Inc (Filed With SEC on June 1, 2020)

Executive Employment Agreement, dated as of June 1, 2020, by and between Axogen Corporation and Brad Ottinger (Filed With SEC on June 1, 2020)

Axogen Inc. 2019 Long-Term Incentive Plan and forms of award notices and agreements thereunder (Filed With SEC on November 6, 2019)

Commercial Lease Amendment 4, dated March 12, 2019, by and between Ja-Cole L.P. and Axogen Corporation (Filed With SEC on May 8, 2019)

Form of Performance Stock Unit Award Agreement pursuant to the Axogen, Inc. 2010 Stock Incentive Plan, as amended and restated as of April 5, 2017 (Filed With SEC on February 26, 2019)

Fourth Amendment to License and Services Agreement, dated as of February 22, 2019, by and between Axogen Corporation and Community Blood Center (d/b/a Community Tissue Services) (Filed With SEC on February 26, 2019)

Executive Employment Agreement dated as of January 21, 2019, by and between AxoGen Corporation and Eric Sandberg (Filed With SEC on January 22, 2019)

Form of Non-Qualified Stock Option Inducement Award Agreement to be granted by AxoGen, Inc. to Eric Sandberg on January 22, 2019 (Filed With SEC on January 22, 2019)

Separation Agreement and General Release, dated January 18, 2019, between AxoGen Corporation and Shawn McCarrey (Filed With SEC on January 18, 2019)

Separation Agreement and General Release, dated January 15, 2019, between AxoGen Corporation and Jon Gingrich (Filed With SEC on January 16, 2019)

AxoGen, Inc. (36)